Mechanism of Zang Medicine Terminaliae belliricae Fructus in Treating Pulmonary Hypertension
摘要
目的 探究藏药毛诃子治疗肺动脉高压(PH)的作用机制和物质基础.方法 通过网络药理学筛选毛诃子活性成分及抗 PH 潜在靶点,构建化合物-靶点网络和靶点 PPI 网络,通过 DAVID 数据库进行富集并分析,获得毛诃子治疗 PH 的潜在作用通路.对网络分析所得到关键化合物与核心靶点进行分子对接及分子动力学模拟,运用表面等离子体共振(SPR)技术,在无标记条件下实时定量测定毛诃子关键活性成分与核心靶点蛋白之间的特异性结合动力学参数.通过脂多糖(LPS)刺激人肺动脉内皮细胞(HPAEC)模拟PH 的炎症微环境,采用鬼笔环肽(FITC-phalloidin)染色观察细胞骨架重塑,Mitotracker 检测线粒体功能,DCFH-DA 探针检测活性氧(ROS)水平,并结合核因子(NF)-κBp 65 免疫荧光分析其核转位情况.结果 网络药理学筛选出毛诃子 29 种活性成分及其 361 个作用靶点,其中 75 个靶点与其治疗 PH 作用密切相关;毛诃子中抗 PH 的关键活性成分可能为 Ellagic acid(EA),其主要作用靶点可能为肿瘤坏死因子(TNF).分子对接及动力学结果显示,EA 与关键靶点 TNF 之间结合稳定,提示 EA 可能通过作用于 TNF 在其抗 PH 中发挥关键作用.SPR 实验结果证实,EA 与核心靶点 TNF 之间的 KD 值3.466×10-5 mol·L-1,表明二者存在高亲和力的特异性结合,验证二者的相互作用.细胞实验结果表明,EA 显著抑制 LPS 诱导的细胞骨架紊乱、线粒体功能障碍和活性氧(ROS)过度积累,并阻断 NF-κB 的活化,从而减轻炎症反应.结论 毛诃子可能通过其关键活性成分 EA 靶向作用于TNF 信号通路发挥抗 PH 的作用.
Objective To explore the mechanism of action and material basis of the Terminaliae belliricae Fructusin in the treatment of pulmonary hypertension(PH).Methods The active ingredients and potential anti-PH targets of Terminaliae belliricae Fructus through network pharmacology were screened.The compound-target network and target PPI network were con-structed.Enrichment and analysis were conducted through the DAVID database to obtain the potential pathways of Terminaliae belliricae Fructus for the treatment of PH.The molecular docking and molecular dynamics simulations of the key compounds and core targets obtained from the network analysis were carried out,and the specific binding kinetic parameters between the key ac-tive ingredients and the core target proteins of Terminaliae belliricae Fructus were quantitatively determined in real time under la-bel-free conditions by using surface plasmon resonance(SPR)technology.The inflammatory microenvironment of PH was simula-ted by LPS stimulation of human pulmonary artery endothelial cells(HPAECs),and cytoskeletal remodeling was observed by stai-ning with FITC-phalloidin staining,mitochondrial function was detected by Mitotracker,and the level of reactive oxygen species(ROS)was detected by the DCFH-DA probe,which was combined with the immunofluorescence analysis of NF-κB p65 its nu-clear translocation.Results A total of 29 active ingredients and their 361 targets of action were screened by network pharmacolo-gy methods in Terminaliae belliricae Fructus,of which 75 targets were closely related to their therapeutic PH effects.The results of network pharmacology showed that ellagic acid(EA)may be the key anti-PH active ingredient in Terminaliae belliricae Fruc-tus,and its target is mainly tumor necrosis factor(TNF),and its molecular docking and molecular dynamics simulation results indicated that the binding between EA and the key target TNF was stable,suggesting that EA may play a key role in its anti-PH by acting on TNF.The results of SPR experiments confirmed the KD value of 3.466×10-5mol·L-1,suggesting that there was a high-affinity specific binding between EA and the core target TNF,validating the interaction between EA and the core target TNF.The results of cellular experiments showed that EA significantly inhibited LPS-induced cytoskeletal disorders,mitochondrial dys-function,and ROS overaccumulation,and blocked NF-κB activation,thereby attenuating inflammatory responses and vascular re-modeling.Conclusion The present study suggests that Terminaliae belliricae Fructus may exert anti-PH effects by targeting the TNF signaling pathway through its key active ingredient EA.